DB
Congress trade
Rep. Donald Beyer (D-VA) sold $1K-$15K of Editas Medicine, Inc. (EDIT) stock
Donald Beyer, U.S. Representative (D-VA), disclosed a sale of Editas Medicine, Inc. (EDIT) stock worth $1K-$15K in a STOCK Act filing on May 1, 2021.
The trade happened on Apr 14, 2021, 17 days before it was made public.
EDIT has moved -93.7% since the trade date, from $41.53 to $2.62 (Oct 2, 2026 close).
- Traded
- Apr 14, 2021
- Disclosed
- May 1, 2021
- Filing delay
- 17 days
- Price since
- -93.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (3)
More EDIT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.